Cell and Gene Therapy Catapult links with Japan’s CiRA Foundation
The groups will explore novel methods to characterise pluripotent stem cells for the manufacture of regenerative medicine products
Read More
Tag: induced pluripotent stem cell
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
